Abstract
Aim:
To observe the preventive and therapeutic effects of Ginkgo biloba extract (GbE) on early experimental diabetic nephropathy (DN) in rats.
Methods:
After an early DN model was induced by streptozotocin, rats were administered GbE at 3 doses for 12 weeks. Fasting blood glucose, creatinine (Cr), blood urea nitrogen (BUN), urine protein, kidney index, anti-oxidase, advanced glycosylation end products (AGE), collagen IV and laminin, matrix metalloproteinases-2 (MMP-2) and the tissue inhibitor of metalloproteinase-2 (TIMP-2), connective tissue growth factor (CTGF), and transforming growth factor-β1 (TGF-β1) mRNA were measured by different methods. The ultrastructural morphology and the thickness of glomerular base membrane (GBM) were observed by a transmission electron microscope.
Results:
For the GbE-treated DN rats, when compared with the vehicle-treated DN rats, the fasting blood glucose level, Cr, BUN, urine protein level, and the intensity of oxidative stress were significantly decreased. The expression of MMP-2 greatly increased, and TIMP-2 decreased. Also, AGE, either in serum or in renal, the collagen IV, laminin, CTGF levels, and TGF-β1 mRNA were reduced. Furthermore, both relative grades of mesangium hyperplasia by microscopical observation and the thickness of GBM by electron microscope measurement decreased significantly.
Conclusion:
GbE has protective effects on several pharmacological targets in the progress of DN and is a potential drug for the prevention of early DN.
Similar content being viewed by others
Article PDF
References
King GL, Wakasaki H . Theoretical mechanisms by which hyperglycemia and insulin resistance could cause cardiovascular diseases in diabetes. Diabetes Care, 1999; 22: C31–7.
Sharma K, McGowan TA . TGF-beta in diabetic kidney disease: role of novel signaling pathways. Cytokine Growth Factor Rev, 2000; 11: 115–23.
Sakharova O V, Taal MW, Brenner BM . Pathogenesis of diabetic nephropathy: focus on transforming growth factor-beta and connective tissue growth factor. Curr Opin Nephrol Hypertens, 2001; 10: 727–38.
Lam S, van der Geest RN, Verhagen NA, van Nieuwenhoven FA, Blom IE, Aten J, et al. Connective tissue growth factor and IGF-I are produced by human renal fibroblasts and cooperate in the induction of collagen production by high glucose. Diabetes, 2003; 52: 2975–83.
Woessner JF . Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J, 1991; 5: 2145–54.
Ross R . Atherosclerosis-an inflammatory disease. N Engl J Med, 1999; 340: 115–26.
Springer TA . Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell, 1994; 76: 301–14.
Akisu M, Kultursay N, Coker I, Huseyinov A . Platelet-activating factor is an important mediator in hypoxic ischemic brain injury in the newborn rat. Flunarizine and Ginkgo biloba extract reduce PAF concentration in the brain. Biol Neonate, 1998; 74: 439–44.
Aminorroaya A, Janghorbani M, Rezvanian H, Aminian T, Gharavi M, Amini M . Comparison of the effect of pentoxifylline and captopril on proteinuria in patients with type 2 diabetes mellitus. Nephron Clin Pract, 2005; 99: C73–7.
Yavuz D, Kucukkaya B, Haklar G, Ersoz O, Akoglu E, Akalin S . Effects of captopril and losartan on lipid peroxidation, protein oxidation and nitric oxide release in diabetic rat kidney release in diabetic rat kidney. Prostaglandins Leukot Essent Fatty Acids, 2003; 69: 223–7.
Blownlee M, Vlassara H, Cerami A . Nonenzymatic glycosylation products on collagen covalently trap low-density lipoprotein. Diabetes, 1985; 34: 938–41.
Wang JY, Yin XX, Wu YM, Tang DQ, Gao YY, Wan MR, et al. Ginkgo biloba extract suppresses hypertrophy and extracellular matrix accumulation in rat mesangial cells. Acta Pharmacol Sin, 2006; 27: 1222–30.
Suzuki YJ, Forman J, Sevanian A . Oxidants as stimulators of signal transduction. Free Radic Biol Med, 1997; 22: 269–85.
Simon AR, Rai U, Fanburg BL, Cochran BH . Activation of the JAK-STAT pathway by reactive oxygen species. Am J Physiol, 1998; 275: C1640–52.
Palmer HJ, Paulson KE . Reactive oxygen species and antioxidants in signal transduction and gene expression. Nutr Rev, 1997; 55: 353–61.
Nath KA, Grande J, Croatt A, Haugen J, Kim Y, Rosenberg ME . Redox regulation of renal DNA synthesis, transforming growth factor-beta1 and collagen gene expression. Kidney Int, 1998; 53: 367–81.
Jerums G, Panagiotopoulos S, Forbes J, Osicka T, Cooper M . Evolving concepts in advanced glycation, diabetic nephropathy, and diabetic vascular disease. Arch Biochem Biophys, 2003; 419: 55–62.
Beisswenger PJ, Makita Z, Curphey TJ, Moore LL, Jean S, Brinck-Johnsen T, et al. Formation of immunochemical advanced glycosylation end products precedes and correlates with early manifestations of renal and retinal disease in diabetes. Diabetes, 1995; 44: 824–9.
Thornalley PJ . Cell activation by glycated proteins, AGE receptors, receptor recognition factors and functional classification of AGEs. Cell Mol Biol, 1998; 44: 1013–23.
Schmidt AM, Hori O, Brett J, Yan SD, Wautier JL, Stern D . Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler Thromb, 1994; 14: 1521–8.
Pugliese G, Pricci F, Romeo G, Pugliese F, Mene P, Giannini S, et al. Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism. Diabetes, 1997; 46: 1881–7.
Akiba S, Chiba M, Mukaida Y, Tamura A, Sato T . The leaf extract of Ginkgo biloba L. suppresses oxidized LDL-stimulated fibronection production through an antioxidant action in rat mesangial cells. Br J Pharmacol, 2004; 142: 419–24.
Wang JY, Yin XX . Relationship between transforming growth factor-beta 1 signal transduction and renal fibrosis of diabetes. Chin J Pharmacol Ther, 2005; 10: 371–6.
Ruperez M, Ruiz-Ortega M, Esteban V, Lorenzo O, Mezzano S, Plaza JJ, et al. Angiotensin II increases connective tissue growth factor in the kidney. Am J Pathol, 2003; 163: 1937–47.
Liu BC, Chen Q, Luo DD, Sun J, Phillips AO, Ruan XZ, et al. Mechanisms of irbesartan in prevention of renal lesion in streptozotocin-induced diabetic rats. Acta Pharmacol Sin, 2003; 24: 67–73.
Tang L, Zhang MX . The effects of Ginkgo biloba extract on TGF-β1 and c-fos expression in kidney of streptozotocin-induced diabetic rats. Acta Med Sin, 2002; 15: 726–9.
Author information
Authors and Affiliations
Corresponding author
Additional information
Project supported by College Natural Science Research Foundation of Jiangsu Province (No 03KJ13360143).
Rights and permissions
About this article
Cite this article
Lu, Q., Yin, Xx., Wang, Jy. et al. Effects of Ginkgo biloba on prevention of development of experimental diabetic nephropathy in rats. Acta Pharmacol Sin 28, 818–828 (2007). https://doi.org/10.1111/j.1745-7254.2007.00570.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2007.00570.x
Keywords
This article is cited by
-
Therapeutic treatments for diabetes mellitus-induced liver injury by regulating oxidative stress and inflammation
Applied Microscopy (2023)
-
Medicinal Plants with Multiple Effects on Diabetes Mellitus and Its Complications: a Systematic Review
Current Diabetes Reports (2018)
-
Over-production of nitric oxide by oxidative stress-induced activation of the TGF-β1/PI3K/Akt pathway in mesangial cells cultured in high glucose
Acta Pharmacologica Sinica (2013)
-
Chinese Medicine for Treating Diabetic Nephropathy
Chinese Journal of Integrative Medicine (2011)